An Oncology Nurse’s Guide to Cancer-Related Ocular Toxicities
Elisa Becze, BA, ELS
Voice
Description
More than 40% of patients receiving antibody-drug conjugates (ADCs) will experience ocular toxicities during treatment, ONS members Caroline Clark, MSN, APRN, OCN®, AGCNS, EBP-C, and Ikuko Komo, MSN, CNS, NP, AOCNS®, AOCNP®, reported in an article in the April 2024 issue of the Clinical Journal of Oncology Nursing.